| February 13 |
Study Published in British Medical Journal The Lancet Shows
Aromasin Improves Overall Survival in Breast Cancer Patients |
| February 13 |
BioLineRx Successfully Completes Phase 1 Clinical Trials of
BL-1020, First in Class GABA-Enhanced Antipsychotic for the
Treatment of Schizophrenia |
| February 13 |
New Survey Reveals Nurses and Patients See Limitations of Commonly
Used Method of Postoperative Pain Management |
| February 13 |
Flu Shot Might Also Offer Some Protection Against H5N1 |
| February 14 |
Peregrine Pharmaceuticals Reports Positive Phase Ib Results for its
Targeted Immunotherapy Bavituximab in Chronic Hepatitis C Infection |
| February 14 |
Genta Cites Publication of Study Showing Improved Outcomes in CLL
Patients Treated With Genasense Plus Chemotherapy |
| February 14 |
Clinical Data Supporting Development of ChemGenex's Ceflatonin in
Imatinib-Resistant CML Published in Cancer |
| February 14 |
Morria Biopharmaceuticals Plc. Announces Publication of the Results
of Its Human Pilot Study in Contact Dermatitis Patients of MRX1, a
Novel First-in-Class MFAID |
| February 14 |
Study Assesses New Communication Techniques Designed to Improve
Dialogue About Migraine Between Healthcare Professionals and
Patients |
| February 14 |
New Instrument Developed to Measure Impact of Migraine on Patients'
Lives When They Are Not Experiencing an Attack |
| February 14 |
Protein Sensor for Fatty Acid Buildup in Mitochondria |
| February 14 |
Genta Cites Publication of Study Showing Improved Outcomes in CLL
Patients Treated with Genasense Plus Chemotherapy |
| February 14 |
Hemispherx Avian Flu Prevention/Treatment Program Announces New
Primate Results and Expands in both Europe and Southern Hemisphere |
| February 14 |
Halozyme Therapeutics and Baxter Present Promising Results for the
Use of Hylenex From the Infuse-Morphine Study |
| February 15 |
The Immune Response Corporation's Interim Phase II Data Suggest
Both REMUNE and IR103 Stabilize CD4+ Cell Counts in Drug-Naive HIV
Patients |
| February 15 |
Unique Structure of Geron's Telomerase Inhibitor Drug Promotes
Anti-Tumor, Anti-Metastatic Activity in Lung Cancer Cells |
| February 15 |
Alagebrium Demonstrates Cardiovascular Activity in Recently
Published Report Indicating Potential Wide-Ranging Benefits in
Cardiovascular Diseases |
| February 15 |
Positive Results with Lacosamide in Diabetic Neuropathic Pain in
Phase III Trial |
| February 15 |
Survey Finds Perceived Risk of Recurrence is Low in African
American Breast Cancer Survivors |
| February 15 |
Gene Network Sciences and UCSD Researchers Discover Connection
Between Metabolic Pathways and Cancer |
| February 15 |
Nasal Flu Vaccines Provide 'Double' Immunity, Carrington Labs Says |
| February 15 |
CDC Report Provides First State-Specific Data on Persons Living
With Heart Disease |
| February 15 |
Researchers Discover New Details About HIV-1 Entry and Infection |
| February 15 |
OXiGENE Announces Positive Results from its Phase II CA4P Clinical
Trial in Myopic Macular Degeneration (MMD-213) |
| February 16 |
Inovio Biomedical DNA Delivery Technology Presented by Wyeth
Researcher at Vaccine Conference |
| February 16 |
Preclinical Efficacy Data on Medivation's MDV3100 to Be Presented
at ASCO-sponsored Prostate Cancer Symposium |
| February 16 |
New Study Shows Cough Medicine Effective Against Prostate Cancer |
| February 16 |
GPC Biotech Schedules Conference Call to Discuss Results from the
Satraplatin Phase 3 Trial Being Presented at the ASCO Prostate
Cancer Symposium in Orlando, Florida |
| February 16 |
Researchers Discover "Sticky" Proteins Fuse Adult Stem Cells to
Cardiac Muscle, Repairing Hearts |
| February 16 |
Mayo Clinic Investigators Demonstrate Degradation of Key Abnormal
Alzheimer's Disease Protein |
| February 16 |
Amgen to Hold Analyst Call to Discuss Danish Head and Neck Cancer
(DAHANCA) 10 Study |
| February 20 |
Auxilium Announces Results from Phase III Trial that Show AA4500
Successful in Treating Dupuytren's Contracture |
| February 20 |
Vyteris Releases Study Estimating the Market for Lidosite Between
$200M - $500M for Use Prior to Blood Draws |
| February 20 |
Alteon's Investigational Drug Alagebrium Demonstrates Ability to
Improve Functional Membrane Transport in a Rat Model of Chronic
Peritoneal Dialysis, Indicating a Potential Role in Kidney Disease |
| February 20 |
Basilea Reports Positive Phase III Results for Alitretinoin |
| February 20 |
BioMarin Announces Results From Phase 2 Clinical Study of 6R-BH4 in
Poorly Controlled Hypertension |
| February 20 |
CeNeS Pharmaceuticals plc Announces Successful Phase III Results on
Lead Product M6G |
| February 20 |
Psoriasis Foundation Consensus Statement Examines Psoriasis
Severity in a New Light |
| February 20 |
H. Lee Moffitt Researchers Discover Potential Targets to Reduce
Risk of Stem Cell Transplants |
| February 20 |
New Data Support AlphaVax's Vaccine for CMV |
| February 20 |
The Medicines Company Supports Landmark Patient Observational Study
and Clinical Survey on Acute Severe Hypertension |
| February 20 |
Researchers Funded by The Leukemia & Lymphoma Society Studying
Agent to Target Gene Linked to Many Forms of Lymphoma |
| February 20 |
RNAi Shows Promise in Gene Therapy, Stanford Researcher Says |
| February 20 |
Stanford Q&A: Largest-Ever Study Shows Possible Genetic Links
for Autism |
| February 20 |
Successful Phase III results announced on Lead Product M6G |
| February 20 |
FDA Warns About Erythropoiesis Stimulating Agents (ESAs) - Results
of Aranesp Study May Apply to Other ESAs |
| February 20 |
Largest-Ever Search for Autism Genes Reveals New Clues |
| February 21 |
GTx Announces Presentation of Acapodene Data At ASCO Prostate
Cancer Symposium |
| February 21 |
BioSante Pharmaceuticals to Present LibiGel at International
Society for the Study of Women's Sexual Health (ISSWSH) Annual
Meeting |
| February 21 |
Sepracor Announces Publication of Additional Data from Lunesta
Insomnia-Depression Study in the Journal of Clinical Sleep Medicine |
| February 21 |
Pre-Clinical Study of Novavax's Seasonal Influenza Vaccine
Published in Journal 'Vaccine' |
| February 21 |
New Long-term Data Published in Journal of Clinical Oncology
Support That Femara Is More Effective Than Tamoxifen |
| February 21 |
Experimental Vaccine Given During Pregnancy Reduces Stillbirths
from Common Virus |
| February 22 |
Hollis-Eden Pharmaceuticals Presents Additional Positive Data with
Novel Steroid Hormone in Models of Prostate and Breast Cancer |
| February 22 |
Poniard Pharmaceuticals Announces Picoplatin Abstract Accepted for
Publication by ASCO's 2007 Prostate Cancer Symposium |
| February 22 |
Cell Genesys and Medarex Announce Encouraging Follow-Up Results
from a Phase 1 Combination Therapy Trial With GVAX Immunotherapy
for Prostate Cancer and Ipilimumab (MDX-010) Antibody |
| February 22 |
Analysis of International Phase III Study of Avastin Plus
Chemotherapy Shows Improved Progression-Free Survival in Patients
With Advanced Lung Cancer |
| February 22 |
Allegiance Equity Corporation Announces Positive Results of In
Vitro Studies and an Open Label Trial for Relieva in Treating
Atopic Dermatitis |
| February 22 |
Cell Genesys and Medarex Announce Encouraging Follow-Up Results
from a Phase 1 Combination Therapy Trial With GVAX(TM)
Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody |
| February 22 |
MediciNova to Present Phase II Clinical Trial Results for MN-001, a
Novel Oral Treatment for Bronchial Asthma, at the 2007 AAAAI Annual
Meeting |
| February 22 |
CureDM, Inc. Achieves Two Drug Discovery Milestones |
| February 23 |
GTx's ACAPODENE Interim Bone Mineral Density and Lipid Data
Highlighted at Press Briefing at Prostate Cancer Symposium of the
American Society of Clinical Oncology |
| February 23 |
Spectrum Pharmaceuticals Announces Satraplatin Data Presentation at
the American Society of Clinical Oncology Prostate Cancer Symposium |
| February 23 |
Satraplatin Shown to Significantly Reduce Risk of Disease
Progression in Advanced Hormone-Refractory Prostate Cancer Patients |
| February 23 |
Significant Phase III Results With Cimzia in Rheumatoid Arthritis |
| February 23 |
Defibrotide Highlighted in Presentation at the 51st Meeting of the
German Society for Thrombosis and Hemostasis |
| February 23 |
Update on Cortex's CEO Presentation at the Roth Capital Partners
19th Annual Conference |
| February 23 |
Crutchfield Dermatology Reports a New Wrinkle in the Quest for
Smooth and Youthful Skin |
| February 23 |
Dynavax Reports Interim, One-Year Data From Ragweed Allergy Trial
at AAAAI |
| February 23 |
Dynavax Announces Webcast on AAAAI Data and 2007 Financial Outlook |
| February 23 |
Treatment Extends Survival in Mouse Model of Spinal Muscular
Atrophy |
| February 23 |
Gamunex Is the Preferred Liquid IGIV Therapy Among Allergists and
Immunologists Surveyed |
| February 23 |
Protox Announces PRX302 Data to Be Presented at ASCO Sponsored
Prostate Cancer Symposium |
| February 23 |
Positive AS1404 Trial Data Presented at ASCO Prostate Cancer
Symposium |
| February 23 |
Cougar Biotechnology Announces Presentation of Positive Phase I and
Phase II Data at ASCO Prostate Cancer Symposium |
| February 26 |
'Encouraging' Major Responses Seen With Xyotax in Patients With
Taxane-Resistant Androgen Independent Prostate Cancer |
| February 26 |
Palatin Technologies and King Pharmaceuticals Announce Presentation
Regarding Clinical Study Evaluating Bremelanotide in
Post-Menopausal Female Sexual Dysfunction Patients |
| February 26 |
Physicians Still Treating Acute Otitis Media (AOM) as They Did
Prior to PCV-7 |
| February 26 |
LifeCycle Pharma Announces Positive Data From LCP-AtorFen Phase I
Clinical Program |
| February 26 |
Steroid-Free Astelin Nasal Spray Demonstrated Seasonal Allergy
Symptom Improvement Within 15 Minutes in Clinical Study |
| February 26 |
Drug Treatment Improves Learning in Mice With Down Syndrome
Symptoms, Stanford/Packard Study Shows |
| February 26 |
Hollis-Eden Pharmaceuticals Reports Publication of Results
Demonstrating the Ability of Neumune to Increase Survival in a
Primate Model of Lethal Radiation Injury |
| February 26 |
Othera Pharmaceuticals Presents New AMD Data at Angiogenesis 2007
Symposium |
| February 26 |
Phase 3 Stroke Trial Shows That Novoseven Reduces Bleeding in the
Brain, but Does Not Improve Long-term Clinical Outcomes |
| February 26 |
Survey Shows Discomfort With Existing Nasal Sprays Causes Allergic
Rhinitis Patients to Discontinue Treatment |
| February 26 |
Medivation's MDV3100 Shown to Be Effective in a Preclinical Model
of Hormone-Refractory Prostate Cancer |
| February 26 |
Gilead Announces Completion of Phase II Clinical Trial of Novel
Investigational HIV Integrase Inhibitor GS 9137 |
| February 26 |
Algeta's Alpharadin significantly improves patient survival in a
clinical trial in prostate cancer |
| February 26 |
Avigen's AV411 Highlighted in Special Issue of Neuron Glia Biology |
| February 26 |
New Clinical Data for Prostascint and Quadramet in Prostate Cancer
Presented at the 2007 Prostate Cancer Symposium |
| February 26 |
Phase 2 Results of Genasense Plus Chemotherapy in Advanced Prostate
Cancer Reported at Cancer Conference |
| February 26 |
LifeCycle Pharma announces positive data from LCP-AtorFen Phase I
clinical program |
| February 27 |
MAP Pharmaceuticals Reports Positive Phase 2 Results for its
Pediatric Asthma Drug Candidate |
| February 27 |
Post-Hoc Data Analyses Published in Annals of Neurology Found
Copaxone Significantly Delayed Accumulated Disability in Male
Patients with Primary Progressive Multiple Sclerosis (PPMS) |
| February 27 |
Increased Prescription Drug Co-pays Linked to Lower Medication
Usage and Higher Hospitalization Rates, Thomson Medstat Study Finds |
| February 27 |
Reported to the American Academy of Allergy, Asthma and Immunology:
Pittsburgh Study Suggests Asthma Medication May Provide Relief for
the Common Cold |
| February 27 |
MatTek's EpiVaginal Excels in Microbicide/HIV Research Study |
| February 27 |
Podcast Alert: Dr. Eli Meltzer Discusses New Data on Fluticasone
Furoate Nasal Spray |
| February 27 |
Studies Showed Fluticasone Furoate Nasal Spray Was Well-Tolerated
and Effective in Treating Allergic Rhinitis in Pediatric Patients |
| February 27 |
New Data Showed Fluticasone Furoate Nasal Spray Effectively Treated
Nasal Symptoms of Allergic Rhinitis |
| February 27 |
Study Finds C1-Inhibitor Concentrate Is Safe and Effective in
Treating Skin Swelling in Patients With Hereditary Angioedema |
| February 27 |
Genitope Corporation to Host Conference Call to Discuss Updated
Blinded Data from Its Phase 3 Clinical Trial |
| February 28 |
TargeGen Announces Successful Completion of Phase I Clinical Trial
of Topical AMD Drug TG100801 |
| February 28 |
Beech Tree Labs' ML-05 Addresses External and Internal Scars |
| February 28 |
Nymox Reports Completion of New Long-term Study of NX-1207 for BPH |
| February 28 |
Mayo Clinic Researchers Safely Regenerate Failing Mouse Hearts With
Programmed Embryonic Stem Cells |
| February 28 |
IL-1 Trap Phase 3 Trial Data Presented at Annual Meeting of
American Academy of Allergy, Asthma and Immunology (AAAAI) |
| February 28 |
Human Genome Sciences Announces Positive Interim Results of Phase
2b Trial of Albuferon With Ribavirin in Treatment-Naive Patients
With Chronic Hepatitis C |
| February 28 |
Review of 1918 Pandemic Flu Studies Offers More Questions than
Answers |
